Home > Boards > US Listed > Biotechs > Soligenix, Inc. (SNGX)

Bought 8k shares at the EOD drop at

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Jiminy Cricket Member Profile
 
Followed By 29
Posts 3,237
Boards Moderated 0
Alias Born 07/29/15
160x600 placeholder
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter PR Newswire (US) - 2/24/2021 7:00:00 AM
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference PR Newswire (US) - 2/11/2021 7:00:00 AM
Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma PR Newswire (US) - 2/1/2021 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/1/2021 6:11:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/26/2021 5:02:29 PM
Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma PR Newswire (US) - 1/19/2021 7:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 1/15/2021 4:31:29 PM
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in th... PR Newswire (US) - 1/7/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 4:31:07 PM
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development PR Newswire (US) - 12/28/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 9:16:25 AM
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and... PR Newswire (US) - 12/22/2020 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/16/2020 4:31:44 PM
Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing PR Newswire (US) - 12/16/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 5:05:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 5:04:07 PM
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine PR Newswire (US) - 12/8/2020 8:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 12/3/2020 4:35:42 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/25/2020 7:32:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 7:30:59 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 7:16:17 AM
Soligenix Announces Recent Accomplishments And Third Quarter 2020 Financial Results PR Newswire (US) - 11/12/2020 7:00:00 AM
Soligenix Invited to Present at Upcoming Virtual Investor Conferences PR Newswire (US) - 11/10/2020 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/6/2020 4:32:56 PM
Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma PR Newswire (US) - 10/22/2020 9:00:00 AM
Jiminy Cricket   Tuesday, 01/26/21 04:05:19 PM
Re: None
Post # of 9152 
Bought 8k shares at the EOD drop at 1.63, great support

Not sure why this tends to happen after conference calls, even good ones

RSI in oversold territory

Good luck to all, hoping for a nice run on FDA.


$SNGX

Honesty is the best policy

DD Support Board and Fraud Research Team
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences